Bupimax Tablet: A High-Demand Psychiatric Product for Your PCD Pharma Franchise

The Growing and Consistent Market for Mental Health Medications

Understanding the Therapeutic Benefits of Bupropion 150mg

Why Bupimax is the Ideal Choice for Your B2B Pharma Portfolio

Quality, Efficacy, and Our Commitment to Your Success
How to Begin Your Monopoly Franchise with a Psychiatric Product

Home/Products /bupropion-150mg-tablet

About the Product

Description


In the critical and consistently high-demand field of mental health, products that offer reliability and proven efficacy are essential. Bupimax Tablet, with its Bupropion (150mg) formulation, is a best-in-class product for the management of major depressive disorder and as a crucial aid in smoking cessation. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.

Bupropion is an antidepressant that acts by inhibiting the reuptake of norepinephrine and dopamine, two key neurotransmitters. Its unique mechanism of action makes it a trusted choice for psychiatrists, particularly for patients who may not respond to other classes of antidepressants. It is also widely prescribed to help individuals quit smoking by reducing cravings and withdrawal symptoms.

At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Bupimax Tablet is manufactured under strict quality controls and comes with a competitive pricing structure. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the mental health and de-addiction segments.

Common side effects may include insomnia, dry mouth, headache, nausea, sweating, or dizziness. Some patients may experience anxiety, tremors, or weight changes. Rare but serious side effects include seizures, allergic reactions, increased blood pressure, or mood changes including suicidal thoughts, particularly in young adults. Any severe or persistent symptoms should be reported immediately to a healthcare provider.

Bupimax Tablet is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid in smoking cessation. It contains Bupropion, an atypical antidepressant that works by inhibiting the reuptake of norepinephrine and dopamine, thereby improving mood, increasing energy levels, and reducing cravings associated with nicotine dependence. The 150 mg dose is typically prescribed as a starting or maintenance dose depending on the condition being treated and patient response.

Bupimax Tablet should be taken exactly as prescribed, usually once or twice daily, and preferably in the morning to avoid insomnia. It should not be stopped abruptly, as sudden discontinuation may worsen mood symptoms or lead to withdrawal effects. Caution is advised in patients with seizure disorders, eating disorders, severe liver or kidney impairment, or those taking other medications that lower the seizure threshold. Alcohol and recreational drugs should be avoided during treatment.

Store Bupimax Tablet in a cool, dry place, below 25°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use the medication beyond the expiry date mentioned on the label.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Bupropion 150mg Tablet in the PCD pharma franchise market?

Bupropion 150mg Tablet has strong demand in the psychiatry and smoking cessation segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on CNS and mental health portfolios.

Why should medical distributors include Bupropion 150mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of depression, seasonal affective disorder, and smoking cessation support therapy. Bupropion is an atypical antidepressant that works on dopamine and norepinephrine pathways This supports a reliable CNS prescription portfolio with chronic usage potential.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Bupropion 150mg Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong psychiatrist prescriptions, chronic therapy demand, smoking cessation clinic usage, steady long-term consumption, reliable supply chain support, and good margins in CNS medicines.

How can I become a distributor or franchise partner for Bupropion 150mg Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.